- Home
- AVR vs IAUX Comparison
AVR vs IAUX Comparison
Compare AVR & IAUX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVR
- IAUX
- Stock Information
- Founded
- AVR 1999
- IAUX 2020
- Country
- AVR Australia
- IAUX United States
- Employees
- AVR N/A
- IAUX N/A
- Industry
- AVR
- IAUX
- Sector
- AVR
- IAUX
- Exchange
- AVR NYSE
- IAUX Nasdaq
- Market Cap
- AVR 241.5M
- IAUX 253.2M
- IPO Year
- AVR 2024
- IAUX N/A
- Fundamental
- Price
- AVR $4.53
- IAUX $0.61
- Analyst Decision
- AVR Strong Buy
- IAUX Buy
- Analyst Count
- AVR 4
- IAUX 1
- Target Price
- AVR $16.50
- IAUX $1.50
- AVG Volume (30 Days)
- AVR 142.8K
- IAUX 9.6M
- Earning Date
- AVR 05-13-2025
- IAUX 05-05-2025
- Dividend Yield
- AVR N/A
- IAUX N/A
- EPS Growth
- AVR N/A
- IAUX N/A
- EPS
- AVR N/A
- IAUX N/A
- Revenue
- AVR $2,493,000.00
- IAUX $55,970,000.00
- Revenue This Year
- AVR $29.52
- IAUX $108.70
- Revenue Next Year
- AVR $204.83
- IAUX $60.68
- P/E Ratio
- AVR N/A
- IAUX N/A
- Revenue Growth
- AVR N/A
- IAUX N/A
- 52 Week Low
- AVR $2.34
- IAUX $0.34
- 52 Week High
- AVR $8.79
- IAUX $1.26
- Technical
- Relative Strength Index (RSI)
- AVR N/A
- IAUX 52.47
- Support Level
- AVR N/A
- IAUX $0.50
- Resistance Level
- AVR N/A
- IAUX $0.54
- Average True Range (ATR)
- AVR 0.00
- IAUX 0.02
- MACD
- AVR 0.00
- IAUX 0.01
- Stochastic Oscillator
- AVR 0.00
- IAUX 94.75
About AVR ANTERIS TECHNOLOGIES GLOBAL CORP
Anteris Technologies Global Corp. is a structural heart company committed to discovering, developing and commercializing medical devices designed to improve the quality of life for patients with aortic stenosis. Its product, the DurAVR THV system, represents a product opportunity in a new THV class of single-piece heart valves, for the treatment of aortic stenosis. Its DurAVR THV system consists of a single-piece, biomimetic valve made with its proprietary ADAPT tissue-enhancing technology and deployed with its ComASUR balloon-expandable delivery system. ADAPT is its proprietary anti-calcification tissue shaping technology that is designed to reengineer xenograft tissue into a pure, single-piece collagen bioscaffold.
About IAUX i-80 Gold Corp.
i-80 Gold Corp is a well-financed gold and silver producer engaged in the exploration, development, and production of gold, silver, and poly-metallic deposits. The Company's principal assets include the Ruby Hill Mine, Lone Tree Mine, Granite Creek Mine, and McCoy-Cove Project.